{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:38:07Z","timestamp":1773869887193,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.rpth.2025.102981","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T23:11:12Z","timestamp":1753485072000},"page":"102981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The impact of protein S and tissue factor pathway inhibitor on coagulation, assessed with thrombin generation, in women starting combined oral contraceptives"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3585-4818","authenticated-orcid":false,"given":"Jesper","family":"Strandberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jette","family":"Nybo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inger Lise","family":"Gade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren Risom","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2025.102981_bib1","series-title":"Contraceptive Use by Method 2019: Data Booklet (ST\/ESA\/SER.A\/435)","year":"2019"},{"key":"10.1016\/j.rpth.2025.102981_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.769187","article-title":"Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk","volume":"12","author":"Morimont","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.rpth.2025.102981_bib3","first-page":"1","article-title":"The risk of venous thromboembolism with different generation of oral contraceptives; a systematic review and meta-analysis","volume":"2","author":"Baratloo","year":"2014","journal-title":"Emerg (Tehran)"},{"key":"10.1016\/j.rpth.2025.102981_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2025.102981_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2025.102981_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.beem.2012.11.002","article-title":"Hormonal contraceptives and venous thromboembolism: an epidemiological update","volume":"27","author":"Plu-Bureau","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.rpth.2025.102981_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.fertnstert.2016.09.027","article-title":"Combined hormonal contraception and the risk of venous thromboembolism: a guideline","volume":"107","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rpth.2025.102981_bib8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archinte.167.3.282","article-title":"Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study","volume":"167","author":"van Vlijmen","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rpth.2025.102981_bib9","series-title":"Combined estrogen-progestin oral contraceptives: patient selection, counselling, and use","author":"Allen","year":"2024"},{"key":"10.1016\/j.rpth.2025.102981_bib10","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.13628","article-title":"A comparison of second and third generations combined oral contraceptive pills\u2019 effect on mood","volume":"16","author":"Shahnazi","year":"2014","journal-title":"Iran Red Crescent Med J"},{"key":"10.1016\/j.rpth.2025.102981_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.contraception.2016.07.007","article-title":"Does the type of progestin influence the production of clotting factors?","volume":"95","author":"Stanczyk","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.rpth.2025.102981_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2025.102981_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1428597","article-title":"Are natural estrogens used in contraception at lower risk of venous thromboembolism than synthetic ones? A systematic literature review and meta-analysis","volume":"15","author":"Douxfils","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.rpth.2025.102981_bib14","article-title":"The benefits of estetrol addition to drospirenone for contraception","volume":"3","author":"Foidart","year":"2023","journal-title":"AJOG Glob Rep"},{"key":"10.1016\/j.rpth.2025.102981_bib15","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.3390\/jcm10235625","article-title":"Estetrol: a new choice for contraception","volume":"10","author":"Fruzzetti","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.rpth.2025.102981_bib16","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s40265-022-01738-8","article-title":"Estetrol\/drospirenone: a review in oral contraception","volume":"82","author":"Lee","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.rpth.2025.102981_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/13625187.2022.2093850","article-title":"A novel estetrol-containing combined oral contraceptive: European expert panel review","volume":"27","author":"Gemzell-Danielsson","year":"2022","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.rpth.2025.102981_bib18","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0002-9378(87)80129-1","article-title":"Coagulation effects of oral contraception","volume":"157","author":"Bonnar","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.rpth.2025.102981_bib19","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1046\/j.1365-2141.2001.02853.x","article-title":"Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-over","volume":"113","author":"Mackie","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.102981_bib20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1542\/peds.2010-2221","article-title":"Hormonal contraception and thrombotic risk: a multidisciplinary approach","volume":"127","author":"Trenor","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.rpth.2025.102981_bib21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/jth.12484","article-title":"Endogenous sex hormones and risk of venous thromboembolism in women and men","volume":"12","author":"Holmegard","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102981_bib22","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1160\/TH12-10-0771","article-title":"The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI","volume":"109","author":"Raps","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102981_bib23","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1160\/TH07-07-0439","article-title":"Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography","volume":"98","author":"Tchaikovski","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102981_bib24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.contraception.2017.01.001","article-title":"Endogenous thrombin potential changes during the first cycle of oral contraceptive use","volume":"95","author":"Westhoff","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.rpth.2025.102981_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206376","article-title":"The effects of oral contraceptive usage on thrombin generation and activated protein C resistance in Saudi women, with a possible impact of the body mass index","volume":"13","author":"Mohamed","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2025.102981_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2141.1999.01302.x","article-title":"Acquired APC resistance and oral contraceptives: differences between two functional tests","volume":"105","author":"Curvers","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.102981_bib27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/1354750X.2016.1204010","article-title":"Sex hormone-binding globulin and thrombin generation in women using hormonal contraception","volume":"22","author":"Hugon-Rodin","year":"2017","journal-title":"Biomarkers"},{"key":"10.1016\/j.rpth.2025.102981_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.thromres.2010.01.045","article-title":"Mechanisms of estrogen-induced venous thromboembolism","volume":"126","author":"Tchaikovski","year":"2010","journal-title":"Thromb Res"},{"issue":"Suppl 1","key":"10.1016\/j.rpth.2025.102981_bib29","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0049-3848(13)70009-4","article-title":"Mechanisms of hormonal therapy related thrombosis","volume":"131","author":"Sandset","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.102981_bib30","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1111\/jth.15025","article-title":"Anticoagulant protein S\u2014new insights on interactions and functions","volume":"18","author":"Gierula","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102981_bib31","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1538-7836.2010.03840.x","article-title":"A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin","volume":"8","author":"Mahmoodi","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102981_bib32","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2021.211010","article-title":"Protein S: a central regulator of blood coagulation","volume":"68","author":"Alshaikh","year":"2022","journal-title":"Clin Lab"},{"key":"10.1016\/j.rpth.2025.102981_bib33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MOH.0000000000000663","article-title":"Protein S: function, regulation, and clinical perspectives","volume":"28","author":"Majumder","year":"2021","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.rpth.2025.102981_bib34","doi-asserted-by":"crossref","DOI":"10.1080\/09537104.2024.2337907","article-title":"The natural anticoagulant protein S; hemostatic functions and deficiency","volume":"35","author":"Alshehri","year":"2024","journal-title":"Platelets"},{"key":"10.1016\/j.rpth.2025.102981_bib35","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/MOH.0b013e328309ec97","article-title":"Regulation of coagulation by protein S","volume":"15","author":"Castoldi","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.rpth.2025.102981_bib36","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/jth.15736","article-title":"Antithrombotic potential of a single-domain antibody enhancing the activated protein C-cofactor activity of protein S","volume":"20","author":"Sedzro","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102981_bib37","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1073\/pnas.0504240103","article-title":"Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor","volume":"103","author":"Hackeng","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rpth.2025.102981_bib38","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/ATVBAHA.108.177436","article-title":"Protein S as cofactor for TFPI","volume":"29","author":"Hackeng","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2025.102981_bib39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/MOH.0000000000000838","article-title":"Tissue factor pathway inhibitor \u2013 cofactor-dependent regulation of the initiation of coagulation","volume":"31","author":"Ahnstr\u00f6m","year":"2024","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.rpth.2025.102981_bib40","doi-asserted-by":"crossref","first-page":"eadk5836","DOI":"10.1126\/sciadv.adk5836","article-title":"TFPI\u03b1 anticoagulant function is highly dependent on protein S in vivo","volume":"10","author":"Petri","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.rpth.2025.102981_bib41","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1182\/blood-2009-11-256610","article-title":"Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain","volume":"115","author":"Andersson","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102981_bib42","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1182\/blood-2004-03-1146","article-title":"Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance","volume":"104","author":"Ser\u00e9","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102981_bib43","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/jth.13657","article-title":"New functional assays to selectively quantify the activated protein C- and tissue factor pathway inhibitor-cofactor activities of protein S in plasma","volume":"15","author":"Alshaikh","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102981_bib44","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1538-7836.2010.03743.x","article-title":"Thrombin generation-based assays to measure the activity of the TFPI-protein S pathway in plasma from normal and protein S-deficient individuals","volume":"8","author":"Maurissen","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"10.1016\/j.rpth.2025.102981_bib45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1538-7836.2009.03363.x","article-title":"Regulation of TFPI function by protein S","volume":"7","author":"Hackeng","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"10.1016\/j.rpth.2025.102981_bib46","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/S0049-3848(08)70021-5","article-title":"Protein S is a cofactor for tissue factor pathway inhibitor","volume":"122","author":"Rosing","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.102981_bib47","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1182\/blood-2014-01-551812","article-title":"TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain","volume":"123","author":"Regli\u0144ska-Matveyev","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102981_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12654","article-title":"Thrombin generation measured on ST Genesia, a new platform in the coagulation routine lab: assessment of analytical and between-subject variation","volume":"6","author":"Kristensen","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102981_bib49","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.metabol.2015.06.011","article-title":"Increased thrombin generation in women with polycystic ovary syndrome: a pilot study on the effect of metformin and oral contraceptives","volume":"64","author":"Glintborg","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.rpth.2025.102981_bib50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/clinem\/dgac511","article-title":"Low thrombin generation in users of a contraceptive containing estetrol and drospirenone","volume":"108","author":"Morimont","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rpth.2025.102981_bib51","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/rth2.12318","article-title":"Thrombin generation in a woman with heterozygous factor V Leiden and combined oral contraceptives: a case report","volume":"4","author":"Zermatten","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102981_bib52","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/aogs.14428","article-title":"Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: a randomized clinical trial","volume":"101","author":"Haverinen","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.rpth.2025.102981_bib53","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/ajh.24064","article-title":"Hypercoagulability in adolescent girls on oral contraceptives-global coagulation profile and estrogen receptor polymorphisms","volume":"90","author":"Zia","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2025.102981_bib54","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12959-025-00713-z","article-title":"The effect of combined oral contraceptives on thrombin generation assessed on ST Genesia\u2013 a paired clinical study","volume":"23","author":"Strandberg","year":"2025","journal-title":"Thromb J"},{"key":"10.1016\/j.rpth.2025.102981_bib55","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1538-7836.2011.04610.x","article-title":"Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol","volume":"10","author":"Lacroix","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102981_bib56","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/00365513.2018.1427280","article-title":"Analytical and between-subject variation of thrombin generation measured by calibrated automated thrombography on plasma samples","volume":"78","author":"Kristensen","year":"2018","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.rpth.2025.102981_bib57","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.thromres.2021.09.018","article-title":"Resistance to activated protein C and impaired TFPI activity in women with previous hormone-induced venous thromboembolism","volume":"207","author":"Tchaikovski","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.102981_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0288918","article-title":"A sensitive tissue factor activity assay determined by an optimized thrombin generation method","volume":"18","author":"Kristensen","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2025.102981_bib59","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2141.1997.192707.x","article-title":"Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives","volume":"97","author":"Rosing","year":"1997","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.rpth.2025.102981_bib60","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/jth.14745","article-title":"Proof of concept of a new scale for the harmonization and the standardization of the ETP-based APC resistance","volume":"18","author":"Morimont","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102981_bib61","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0010-7824(02)00476-6","article-title":"The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study","volume":"67","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.rpth.2025.102981_bib62","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.contraception.2020.08.015","article-title":"Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters","volume":"102","author":"Douxfils","year":"2020","journal-title":"Contraception"},{"key":"10.1016\/j.rpth.2025.102981_bib63","article-title":"Combined oral contraceptives: venous thrombosis","volume":"2014","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rpth.2025.102981_bib64","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1182\/blood-2008-06-164087","article-title":"Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera","volume":"112","author":"Marchetti","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102981_bib65","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2141.2001.03111.x","article-title":"Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial","volume":"115","author":"H\u00f8ibraaten","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.102981_bib66","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.thromres.2007.08.010","article-title":"Sensitivity to activated protein C during the menstrual cycle in women with and without factor VLeiden","volume":"121","author":"van Vliet","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.102981_bib67","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1538-7836.2011.04546.x","article-title":"Genetic modulation of the FVLeiden\/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotes","volume":"10","author":"Segers","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102981_bib68","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.thromres.2023.07.007","article-title":"Estimation of the preanalytical activation of the contact system in coagulation tubes","volume":"229","author":"Kristensen","year":"2023","journal-title":"Thromb Res"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247503792500305X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247503792500305X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T14:15:27Z","timestamp":1773843327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S247503792500305X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S247503792500305X"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2025.102981","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of protein S and tissue factor pathway inhibitor on coagulation, assessed with thrombin generation, in women starting combined oral contraceptives","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2025.102981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102981"}}